Filing Details
- Accession Number:
- 0001140361-17-011981
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-14 20:29:59
- Reporting Period:
- 2017-03-10
- Filing Date:
- 2017-03-14
- Accepted Time:
- 2017-03-14 20:29:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1437402 | Ardelyx Inc. | ARDX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1611311 | P. David Rosenbaum | C/O Ardelyx, Inc. 34175 Ardenwood Blvd, Suite 100 Fremont CA 94555 | Svp, Drug Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-03-10 | 1,000 | $13.48 | 1,277 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 42,180 | Direct | |
Common Stock | 77,592 | Indirect | See Footnote |
Footnotes
- Includes 364 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2017.
- Consists of 1,277 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2017.
- The shares are directly held by the Reporting Person's wife.
- Includes (i) 2,051 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2017 and (ii) 17,985 restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.
- The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.